Companies:
49,743
Total Market Cap:
136748121246454.23
Global Rank
#25094
Country Rank
#1190
Market Cap
92.57 M
Price
1.09
Change (%)
0.20%
Volume
255,636
HLB bioStep Co.,Ltd.'s latest marketcap:
92.57 M
As of 06/26/2025, HLB bioStep Co.,Ltd.'s market capitalization has reached $92.57 M. According to our data, HLB bioStep Co.,Ltd. is the 25094th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 92.57 M |
| Revenue (ttm) | 44.11 M |
| Net Income (ttm) | -5,912,087.73 |
| Shares Out | 84.47 M |
| EPS (ttm) | -0.07 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
Market Cap Chart
Data Updated: 06/26/2025
HLB bioStep Co.,Ltd.'s yearly market capitalization.
HLB bioStep Co.,Ltd. has seen its market value drop from ₩150.36 B to ₩92.57 M since 2019, representing a total decrease of 99.94% and an annual compound decline rate (CAGR) of 73.98%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | ₩92.57 M | -25.2% | 25094 |
| 12/30/2024 | ₩176.39 B | -27.37% | 22201 |
| 12/28/2023 | ₩242.88 B | -25.95% | 19202 |
| 12/29/2022 | ₩327.97 B | 49.6% | 16489 |
| 12/30/2021 | ₩219.23 B | 14.63% | 19320 |
| 12/30/2020 | ₩191.25 B | 27.19% | 17451 |
| 12/30/2019 | ₩150.36 B | 16814 |
Company Profile
About HLB bioStep Co.,Ltd.
HLB bioStep Co.,Ltd. is a specialized provider of comprehensive test services, catering to diverse research and development needs. Formerly known as KNOTUS Co.,Ltd., the company was established in 2012 and operates from Incheon, South Korea.
Core Services
- Platform Technology Services: Includes cell-enzyme-based screening, xenograft assay, mitogenic effect test, vaccine antigen development, antibody titration, cytokine analysis, MRNA expression studies, and more.
- Pharmacokinetic & Toxicology Studies: Offers in-depth PK/toxico studies, toxicology assessments, and biological drug evaluations.
- Pathology Services: Provides toxic and clinical pathology services to support research and regulatory requirements.
Specialized Testing Capabilities
- Trachea relaxation assay
- Carrageenan and adjuvant-induced paw edema tests
- Antipyretic and anti-pain evaluations
- Isolated blood vessel screening
- Fibrin plate lysis screening
- Ferric chloride and food diet-induced models
- Gastric acid secretion and emesis model studies
- MIC test and post-antibody effect analysis
- Enzyme assays and systemic/local infection models
- PK studies for chemical and transgenic animal research
- Osteoblast-like cell line screening and bone formation marker analysis
- Biomarker identification and validation
Frequently Asked Questions
-
What is HLB bioStep Co.,Ltd.'s (KOSDAQ-278650) current market cap?As of 06/26/2025, HLB bioStep Co.,Ltd. (including the parent company, if applicable) has an estimated market capitalization of $92.57 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does HLB bioStep Co.,Ltd. (KOSDAQ-278650) rank globally by market cap?HLB bioStep Co.,Ltd. global market capitalization ranking is approximately 25094 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.